Figure 7.Schematic diagram of the effect of Val combined with MSCs on DOX-induced apoptosis in H9c2 cardiomyocytes.
Figure 7 — MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway | Aging
